


OnCusp Therapeutics Email Formats
Pharmaceutical Manufacturing • Manhattan, New York, United States • 21-50 Employees
OnCusp Therapeutics Email Formats
OnCusp Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@oncusptx.com), used 83.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@oncusptx.com | 83.3% |
{first name}.{last name} | john.doe@oncusptx.com | 16.7% |
Key Contacts at OnCusp Therapeutics
Chenhui Roy
Director Of Business Development
Eric Slosberg
Co-Founder, Chief Development Officer, Head Of Research And Development
Nicole Covino
Senior Director Project Management
立川 季
Financial Director
Company overview
| Headquarters | 433 Broadway, New York, New York 10013, US |
| Website | |
| NAICS | 3254 |
| Keywords | Pharmaceutical, Biotech, Oncology |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
About OnCusp Therapeutics
OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
OnCusp Therapeutics has 10 employees across 7 departments.
Departments
Number of employees
OnCusp Therapeutics Tech Stack
Discover the technologies and tools that power OnCusp Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Analytics
JavaScript libraries
Web frameworks
Documentation
Miscellaneous
Frequently asked questions
4.8
40,000 users



